跳至主要内容
临床试验/NCT04402801
NCT04402801已完成不适用

Impact on Patient Outcomes of Clinic Transition From Face to Face Encounters to Telemedicine in the Cystic Fibrosis (CF) Adult Population at UVA

University of Virginia1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
1
主要终点
FEV1 stability

研究概览

简要总结

Adult patients with Cystic Fibrosis who are seen at the specialty CF clinic at University of Virginia will be given an option to utilize telemedicine instead of in-person visits for standard clinic visits. Health information from standard of care visits including FEV1, exacerbations, leading to oral or intravenous antibiotics, laboratory results, hospitalization records, and responses to health questionnaires will be recorded for research purposes. Data collected for the research study will be compared to baseline and previous years to determine if there are any deleterious effects for those who transition to telemedicine clinic visits.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (18-year-old and older) with CF seen in the UVA adult CF clinic who agree to participate in the study.

排除标准

  • Patients who cannot consent to the research study. In addition, prisoners will not be included.

结局指标

主要结局

FEV1 stability

时间窗: 12 months

A change of 10% or more in FEV1 percent predicted will be considered significant; FEV1 pre and pos covid telemedicine implementation will be compared

次要结局

  • Exacerbation rate(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dana Albon, MD

Assistant Professor

University of Virginia

研究点 (1)

Loading locations...

相似试验